| Heart disease and stroke statistics—2013 update: a report from the American Heart Association AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, WB Borden, ... circulation 127 (1), e6-e245, 2013 | 58232* | 2013 |
| Apixaban versus warfarin in patients with atrial fibrillation CB Granger, JH Alexander, JJV McMurray, RD Lopes, EM Hylek, ... New England Journal of Medicine 365 (11), 981-992, 2011 | 11420 | 2011 |
| 2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation developed … Authors/Task Force Members, AJ Camm, GYH Lip, R De Caterina, ... European heart journal 33 (21), 2719-2747, 2012 | 6605 | 2012 |
| Initial invasive or conservative strategy for stable coronary disease DJ Maron, JS Hochman, HR Reynolds, S Bangalore, SM O’Brien, ... New England Journal of Medicine 382 (15), 1395-1407, 2020 | 2284 | 2020 |
| Sotagliflozin in patients with diabetes and recent worsening heart failure DL Bhatt, M Szarek, PG Steg, CP Cannon, LA Leiter, DK McGuire, ... New England journal of medicine 384 (2), 117-128, 2021 | 1714 | 2021 |
| Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial AF Hernandez, JB Green, S Janmohamed, RB D'Agostino, CB Granger, ... The Lancet 392 (10157), 1519-1529, 2018 | 1528 | 2018 |
| Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX randomized clinical trial BM Tomazini, IS Maia, AB Cavalcanti, O Berwanger, RG Rosa, VC Veiga, ... Jama 324 (13), 1307-1316, 2020 | 1402 | 2020 |
| Apixaban with antiplatelet therapy after acute coronary syndrome JH Alexander, RD Lopes, S James, R Kilaru, Y He, P Mohan, DL Bhatt, ... New England Journal of Medicine, 2011 | 1355 | 2011 |
| Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo … PM Ridker, JG MacFadyen, T Thuren, BM Everett, P Libby, RJ Glynn, ... The Lancet 390 (10105), 1833-1842, 2017 | 1335 | 2017 |
| Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19 AB Cavalcanti, FG Zampieri, RG Rosa, LCP Azevedo, VC Veiga, ... New England Journal of Medicine 383 (21), 2041-2052, 2020 | 1326 | 2020 |
| Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation RD Lopes, G Heizer, R Aronson, AN Vora, T Massaro, R Mehran, ... New England Journal of Medicine 380 (16), 1509-1524, 2019 | 1227 | 2019 |
| Sotagliflozin in patients with diabetes and chronic kidney disease DL Bhatt, M Szarek, B Pitt, CP Cannon, LA Leiter, DK McGuire, JB Lewis, ... New England Journal of Medicine 384 (2), 129-139, 2021 | 1061 | 2021 |
| Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials N Sattar, MMY Lee, SL Kristensen, KRH Branch, S Del Prato, NS Khurmi, ... The lancet Diabetes & endocrinology 9 (10), 653-662, 2021 | 983 | 2021 |
| Thrombin-receptor antagonist vorapaxar in acute coronary syndromes P Tricoci, Z Huang, C Held, DJ Moliterno, PW Armstrong, F Van de Werf, ... New England Journal of Medicine 366 (1), 20-33, 2012 | 924 | 2012 |
| Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial SH Hohnloser, Z Hijazi, L Thomas, JH Alexander, J Amerena, M Hanna, ... European heart journal 33 (22), 2821-2830, 2012 | 749 | 2012 |
| Myocarditis cases reported after mRNA-based COVID-19 vaccination in the US from December 2020 to August 2021 ME Oster, DK Shay, JR Su, J Gee, CB Creech, KR Broder, K Edwards, ... Jama 327 (4), 331-340, 2022 | 696 | 2022 |
| Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale RD Lopes, JH Alexander, SM Al-Khatib, J Ansell, R Diaz, JD Easton, ... American heart journal 159 (3), 331-339, 2010 | 611 | 2010 |
| Diagnosis and treatment of acute coronary syndromes: a review DL Bhatt, RD Lopes, RA Harrington Jama 327 (7), 662-675, 2022 | 589 | 2022 |
| The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study Z Hijazi, J Oldgren, J Lindbäck, JH Alexander, SJ Connolly, ... The Lancet 387 (10035), 2302-2311, 2016 | 567 | 2016 |
| Cardiovascular and renal outcomes with efpeglenatide in type 2 diabetes HC Gerstein, N Sattar, J Rosenstock, C Ramasundarahettige, R Pratley, ... New England journal of medicine 385 (10), 896-907, 2021 | 547 | 2021 |
